The European Hematology Association (EHA)
  • Welcome
  • Introduction to CAR T cell therapy
  • Current clinical landscape for CAR T in Europe
  • Clinical and regulatory implementation of CAR T in Europe
  • Future developments
  • EHA Topics-in-Focus: Immunotherapy

The European Hematology Association (EHA)

  • Menu

Webinars


Back

Hudecek - New targets and technologies for CAR-T cells – Friday, session 5

Gudipati - Oral 1.3 - Attenuated membrane-proximal signaling limits the antigen sensitivity of CAR T Cells – Thursday, Best abstracts & flash talks I

Wallstabe - Oral 2.3 - CAR T cells specific for ROR1 are effective against lung and breast cancer in advanced micro-physiologic 3D tumor models – Friday, session 7

Cazaux - Oral 2.4 - Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity – Friday, session 7

EHA Executive Office - Koninginnegracht 12b, 2514 AA - The Hague, The Netherlands
Phone: +31 (0)70 3020 099 Email: info@ehaweb.org KvK-number 24334797

© Copyright 2017 - European Hematology Association All rights reserved.
Web design: Loyals